Polrat WilairatanaNoppadon TangpukdeeShigeyuki KanoSrivicha KrudsoodMahidol UniversityNational Center for Global Health and Medicine2018-09-242018-09-242010-01-01Korean Journal of Parasitology. Vol.48, No.2 (2010), 175-17717380006002340012-s2.0-77954435375https://repository.li.mahidol.ac.th/handle/20.500.14594/29282Mixed infections of Plasmodium falciparum and Plasmodium vivax is high (~30%) in some malaria hypoendemic areas where the patients present with P. falciparum malaria diagnosed by microscopy. Conventional treatment of P. falciparum with concurrent chloroquine and 14 days of primaquine for all falciparum malaria patients may be useful in areas where mixed falciparum and vivax infections are high and common and also with mild or moderate G6PD deficiency in the population even with or without subpatent vivax mixed infection. It will be possibly cost-effective to reduce subsequent vivax illness if the patients have mixed vivax infection. Further study to prove this hypothesis may be warranted.Mahidol UniversityImmunology and MicrobiologyMedicinePrimaquine administration after falciparum malaria treatment in malaria hypoendemic areas with high incidence of falciparum and vivax mixed infection: Pros and consArticleSCOPUS10.3347/kjp.2010.48.2.175